Paragon 28, Inc. (NYSE: FNA), relating to the proposed merger with Zimmer Biomet Holdings, Inc. Under the terms of the agreement, Zimmer Biomet will acquire all outstanding shares of Paragon 28 common stock for $13.00 per share. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitling holders to receive up to $1.00 per share in cash if certain revenue milestones are achieved.